Adults with certain types of cancer may receive chemotherapy treatment with a drug called BiCNU® (carmustine). This prescription medicine is specifically approved for use in adults and is licensed to treat the following cancers:
- Brain tumors
- Multiple myeloma (a cancer of the bone marrow)
- Hodgkin's lymphoma
- Non-Hodgkin's lymphoma.
BiCNU belongs to a group of medicines known as alkylating agents. It contains the active drug carmustine, which is sometimes referred to as BCNU because its chemical name is bis-chloroethylnitrosourea.
This medicine works by interfering with the process needed for cells to grow and multiply. BiCNU is given as a slow injection into a vein (intravenous, or IV, infusion). Side effects may include nausea, vomiting, and low blood cell counts.
(To learn more about this chemotherapy drug, including more details on how it works, click BiCNU.)